Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options

Posted by  | Research, treatment

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may(...)

NSCLC Treatment Gets Specific with Next-Gen Sequencing, Cell-Free DNA

Posted by  | Research

During a presentation on advanced non-small cell lung cancer (NSCLC), Ben Levy, M.D., a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, said there is a new opportunity for clinicians to be more specific when targeting mutations in those cancer patients.(...)

Cancer Matters with Dr. Bill Nelson – 45th Anniversary

Cancer Matters with Dr. Bill Nelson – 45th Anniversary

Posted by  | podcast

2018 marks the 45th anniversary of the founding of our Cancer Center. In our latest podcast, Dr Bill Nelson talks with Sharon Krumm, Director of Nursing Administration, and Senior Science Writer Valerie Mehl about some of the most notable achievements of the past 45 years. In this preview, they discuss the opening of the new(...)

Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer

Posted by  | Issues & Perspectives, Research, Survivorship

Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention(...)

Cancer Matters with Dr. Bill Nelson – Bladder Cancer in Women

Cancer Matters with Dr. Bill Nelson – Bladder Cancer in Women

Posted by  | podcast

In our next podcast, Dr Bill Nelson talks with Dr Jean Hoffman-Censits and Dr Armine Smith, from the Johns Hopkins Greenberg Bladder Cancer Institute, about the complications that arise in diagnosing and treating bladder cancer in women.   In this preview, they explain why women often learn about their diagnosis much later than men do.(...)

Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers

Posted by  | Issues & Perspectives, Prevention/Screening, Research

Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of HPV-related cancers. The panel was just one section of the Washington Post Cancer Summit. Viswanathan was joined by other experts in taking look at rising HPV-related cancer rates in the(...)

Cancer Matters with Dr. Bill Nelson – Managing the Adverse Effects of Immunotherapy Treatment

Cancer Matters with Dr. Bill Nelson – Managing the Adverse Effects of Immunotherapy Treatment

Posted by  | podcast

In our next podcast, Dr Bill Nelson speaks to Dr Jarushka Naidoo about monitoring and treating the side effects of cancer immunotherapy treatment. In this preview, Dr Bill Nelson speaks to Dr Jarushka Naidoo about monitoring and treating the side effects of cancer immunotherapy treatment. To listen to the entire podcast, click here: https://bit.ly/2QKMFuo